Korkmaz, Sevil <br/><br/>
Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.  [electronic resource] 

 -  Circulation  Aug 2009 
 - 677-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.109.870774  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic beta-Agonists--toxicity<br/>Animals<br/>Benzoates--pharmacology<br/>Cardiotonic Agents--pharmacology<br/>Cyclic AMP--blood<br/>Cyclic GMP--blood<br/>Cyclooxygenase 2--genetics<br/>Dogs<br/>Female<br/>Gene Expression--drug effects<br/>Guanylate Cyclase--metabolism<br/>Heart Function Tests--drug effects<br/>Isoproterenol--toxicity<br/>L-Lactate Dehydrogenase--blood<br/>Male<br/>Myocardial Infarction--chemically induced<br/>Myocardial Reperfusion Injury--chemically induced<br/>Myocardium--pathology<br/>Nitric Oxide--metabolism<br/>Peroxynitrous Acid--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Cytoplasmic and Nuclear--agonists<br/>Soluble Guanylyl Cyclase<br/>Survival Rate<br/>Thiobarbituric Acid Reactive Substances--metabolism<br/>Transforming Growth Factor beta1--genetics